| abstract |
Pharmaceutical composition containing at least one compatible solute selected from compounds from S-ectoine, R-ectoine, (S, S) -hydroxyectoine, (S, R) -hydroxyectoine, (R, S) -hydroxyectoine and / or (R, R) -Hydroxyectoin or containing a solute mixture of at least two of the aforementioned compounds for use in the prevention or treatment of diseases of the eye, which has at least one barrier defect of the outer epithelial tissue of the eye with a disturbed and reduced selective permeability barrier, which is caused by at least one bio-based toxin . |